Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies

BACKGROUND: Treatment of everolimus-resistant disease remains largely undefined in metastatic renal cell carcinoma (mRCC). We report on 40 patients (pts) who receive systemic treatment after failure of everolimus. PATIENTS AND METHODS: Forty pts received sunitinib (n=19), sorafenib (n=8), dovitinib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Grünwald, V, Seidel, C, Fenner, M, Ganser, A, Busch, J, Weikert, S
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2011
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242587/
https://ncbi.nlm.nih.gov/pubmed/22033275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.389
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars